share_log

Bright Minds Biosciences | 6-K: Bright Minds Biosciences Appoints Drug Development Executive Mark A. Smith as Chief Medical Officer

Bright Minds Biosciences | 6-K:Bright Minds Biosciences任命Mark A. Smith為首席醫療官

2022/11/23 17:21
声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息